Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-81,165.45
% of Total Estimate Gain
-30.43%

1290 Avantis U.S. Large Cap Growth Fund's West Pharmaceutical Services Inc Holding Summary

As of 2025-04-30, 1290 Avantis U.S. Large Cap Growth Fund held - shares of West Pharmaceutical Services Inc(WST), totaling N/A. This investment constitutes 0% of their stock portfolio, and 1290 Avantis U.S. Large Cap Growth Fund now holds 0% of the outstanding West Pharmaceutical Services Inc(WST) stock.

The initial trade took place in 2024Q1. And since then 1290 Avantis U.S. Large Cap Growth Fund has made 3 purchases of WST, at an average price of $336.83, for a total of 792.00 shares. In addition, there have been 1 sales at an average price of $234.35 for 792.00 shares. Based on historical transaction data and WST's current price of $227.18, 1290 Avantis U.S. Large Cap Growth Fund's estimated gain on his WST holdings is $-81,165.45, reflecting a -30.43% gain to date.

1290 Avantis U.S. Large Cap Growth Fund WST ($227.18) Holding Chart

1290 Avantis U.S. Large Cap Growth Fund WST ($227.18) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1